knowledge -WSS

knowledge

author：fashion 2025-09-05 07:02:24 - browse：1

Under the Affordable Care Act, health insurers are required to cover all costs associated with preventive care — including PrEP, or pre-exposure prophylactic treatment for HIV. But now all preventive care coverage is under threat, thanks to a lawsuit filed by employers who believe they shouldn’t be required to pay for care that violates their religious beliefs.

While coverage for PrEP access is largely unchanged as the court case makes its way through the legal system, Richard Hughes IV, a partner with the law firm Epstein Becker Green, says that protecting the status quo isn’t enough. For instance, currently you have to jump through extra hoops to get long-acting injectable PrEP covered by insurance.

But Hughes has a better idea for how to not only protect but also expand access to PrEP.

On this episode of the “First Opinion Podcast,” I spoke to Hughes about his proposal, why access to PrEP has never been what it should be, the Supreme Court’s current approach to health care, and more.

“If a provider has a bad experience with a previous patient experiencing non-coverage, they might say to the next patient, ‘Well, I’m not sure this is going to be covered.’ And that can be really discouraging,” Hughes said. “What we really need to create that clarity for patients is for this law to be upheld, for the recommendations to be clear, and for providers to have the assurance that they will be covered by payers.”

Our conversation was based on his recent First Opinion op-ed, “How to protect PrEP coverage, no matter what happens in Braidwood v. Becerra.”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Stitcher, Google Play, or wherever you get your podcasts.

And if you have any feedback for us — First Opinion authors to feature on the podcast, kudos, or darts — email us at [email protected] and please put “podcast” in the subject line.

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Coloradans with cystic fibrosis could lose access to Trikafta

WSS

Inequities make cancer less preventable for women: report

Sudafed saga points to U.S. issues with evaluating older drugs

STAT Virtual Event: How to Increase Diversity in Clinical Trials

Cigna to pay $172 million to settle Medicare Advantage fraud probe

Biogen shutters digital health group, ends Apple study, in cost cutting move

All of Us, NIH's precision medicine initiative, gets a big boost

Wikipedia

knowledge

hotspot

In Memoriam: Notable people who died in 2023

STAT Readout: The latest on Wegovy, Mounjaro, and Covid shots

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Health tech startups drop sharply from 2021 highs

Medical leaders decry Supreme Court decision on affirmative action

Live blog: Hearing on CRISPR

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

How to convince healthy people to buy insurance

What does generative AI mean for health care? We asked experts

Data show record exodus of life scientists from academia

Wikipedia

Kaiser Permanente unions announce official strike date

How the Dana

Readout Newsletter: Medeor's stem cell study, Moderna's stock dip

Kidney transplant patients stopped immunosuppressants in trial

STAT Readout: The latest on Wegovy, Mounjaro, and Covid shots

Senator probes 340B programs at Cleveland Clinic, Bon Secours

knowledge

focus

hotspot

leisure time